Aby Buchbinder
2013
In 2013, Aby Buchbinder earned a total compensation of $515.1K as Former Vice President, Clinical Development at Enzon Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
Salary | $91,044 |
---|---|
Other | $424,081 |
Total | $515,125 |
Buchbinder received $424.1K in other compensation, accounting for 82% of the total pay in 2013.
Buchbinder also received $91K in salary.
Rankings
In 2013, Aby Buchbinder's compensation ranked 9,263rd out of 12,286 executives tracked by ExecPay. In other words, Buchbinder earned more than 24.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,263 | 25th |
Manufacturing | 3,390 | 27th |
Chemicals And Allied Products | 1,073 | 27th |
Drugs | 824 | 29th |
Biological Products, Except Diagnostic Substances | 135 | 31st |
Buchbinder's colleagues
We found five more compensation records of executives who worked with Aby Buchbinder at Enzon Pharmaceuticals in 2013.
2013
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2013
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2013
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2013
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
2013
Richard Feinstein
Enzon Pharmaceuticals